ACTA1 and malignant colon neoplasm: In addition, knockdown of either PIK3CA or SLC6A6 resulted in decreased expression of α-SMA and increased expression of E-cadherin along with decreases in CD44, CD133, and Nanog, indicating a loss in markers for EMT and colon cancer stem cells (Figure 7B,D).